array(3) {
["company_details"]=>
array(13) {
["name"]=>
string(25) "Gsk Consumer Health, Inc."
["slug"]=>
string(32) "4abba-us-gsk-consumer-health-inc"
["logo"]=>
string(84) "https://images.businessradar.com/linkedin_logos/8434ac9a-9bf2-4877-a3a0-a4039c237204"
["description"]=>
string(518) "GSK Consumer Healthcare is a global business that discovers, develops, and manufactures innovative consumer healthcare products. It is an associate of GlaxoSmithKline plc, one of the world's largest healthcare companies. GSK Consumer Healthcare aims to become one of the world's most innovative, best performing, and trusted healthcare companies. Their goal is to improve lives through scientific innovation, build category-defining brands, and become Pakistan's first and best Fast Moving Consumer Healthcare Company."
["address_street"]=>
string(28) "184 Liberty Corner Rd Ste 78"
["address_place"]=>
string(6) "Warren"
["address_region"]=>
string(10) "New Jersey"
["founding_date"]=>
string(10) "1994-02-28"
["website_domain"]=>
string(7) "gsk.com"
["website_url"]=>
string(19) "https://www.gsk.com"
["industry_codes"]=>
array(1) {
[0]=>
string(27) "Pharmaceutical Preparations"
}
["employee_count"]=>
int(300)
["article_count"]=>
int(449)
}
["articles"]=>
array(9) {
[0]=>
array(7) {
["title_en"]=>
string(83) "Legal Battle: GSK Sues Pfizer and BioNTech for COVID-19 Vaccine Patent Infringement"
["snippet_en"]=>
string(157) "GlaxoSmithKline (GSK) has filed a lawsuit against Pfizer and BioNTech in Delaware federal court, alleging that the companies’ COVID-19 vaccines, Comirnaty,"
["url"]=>
string(108) "https://newswherever.com/legal-battle-gsk-sues-pfizer-and-biontech-for-covid-19-vaccine-patent-infringement/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/5caeac9c-2562-45fe-bd7a-85cd8a9780a3"
["source"]=>
string(16) "newswherever.com"
["publication_date"]=>
string(10) "2024-02-04"
["categories"]=>
array(7) {
[0]=>
string(8) "Epidemic"
[1]=>
string(21) "Intellectual Property"
[2]=>
string(46) "Management of Legal and Regulatory Environment"
[3]=>
string(17) "Business Disputes"
[4]=>
string(8) "Verdicts"
[5]=>
string(10) "Litigation"
[6]=>
string(5) "Legal"
}
}
[1]=>
array(7) {
["title_en"]=>
string(99) "Emergen-C class action claims beverage mix falsely advertised as containing 'natural fruit flavors'"
["snippet_en"]=>
string(187) "GSK Consumer Health falsely advertises that its Emergen-C brand raspberry flavored immune supporting beverage mix contains “Natural fruit flavors,” a new class action lawsuit alleges."
["url"]=>
string(159) "https://topclassactions.com/lawsuit-settlements/lawsuit-news/emergen-c-class-action-claims-beverage-mix-falsely-advertised-as-containing-natural-fruit-flavors/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/0e8bbaeb-5c22-43c7-a64a-22810fe37b99"
["source"]=>
string(19) "topclassactions.com"
["publication_date"]=>
string(10) "2023-09-04"
["categories"]=>
array(3) {
[0]=>
string(10) "Litigation"
[1]=>
string(39) "Selling practices and product labelling"
[2]=>
string(5) "Legal"
}
}
[2]=>
array(7) {
["title_en"]=>
string(54) "GSK sues Pfizer for patent infringement on RSV vaccine"
["snippet_en"]=>
string(289) "GSK sued Pfizer this Wednesday before the General Court of Delaware (United States). The British pharmaceutical company alleges that the vaccine against Respiratory Syncytial Virus from the American giant (Abrysvo) violates the patent rights of its own (Arexvy), as published by the agency"
["url"]=>
string(133) "https://www.eleconomista.es/salud/noticias/12394911/08/23/gsk-demanda-a-pfizer-por-infraccion-de-patente-sobre-la-vacuna-del-vrs.html"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/0a79811c-d240-43ef-b8b1-170005edaa8d"
["source"]=>
string(15) "eleconomista.es"
["publication_date"]=>
string(10) "2023-08-02"
["categories"]=>
array(4) {
[0]=>
string(27) "Business Model & Innovation"
[1]=>
string(5) "Legal"
[2]=>
string(21) "Competitive Behaviour"
[3]=>
string(10) "Litigation"
}
}
[3]=>
array(7) {
["title_en"]=>
string(64) "GSK Consumer Health $6.5 Million Benefiber False Ad Deal Gets OK"
["snippet_en"]=>
string(200) "A $6.5 million nationwide class settlement between GSK Consumer Health Inc. and customers alleging it deceptively marketed certain Benefiber products got the initial nod from a New York federal court."
["url"]=>
string(106) "https://news.bloomberglaw.com/class-action/gsk-consumer-health-6-5-million-benefiber-false-ad-deal-gets-ok"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/277eca4d-d033-4ddd-ad76-f841866de55f"
["source"]=>
string(16) "bloomberglaw.com"
["publication_date"]=>
string(10) "2021-06-09"
["categories"]=>
array(4) {
[0]=>
string(10) "Litigation"
[1]=>
string(46) "Management of Legal and Regulatory Environment"
[2]=>
string(5) "Legal"
[3]=>
string(16) "Case Settlements"
}
}
[4]=>
array(7) {
["title_en"]=>
string(64) "Vectura, Sandoz win ruling on inhaler packaging case against GSK"
["snippet_en"]=>
string(157) "Vectura Group said on Friday a British court had ruled in its favor on the packaging of a generic version of an inhaler made by bigger rival GlaxoSmithKline."
["url"]=>
string(46) "https://www.reuters.com/article/idUSKBN1WJ1PI/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/70e3d36f-ac9e-4bc8-9a52-1c6108de6938"
["source"]=>
string(11) "reuters.com"
["publication_date"]=>
string(10) "2019-10-04"
["categories"]=>
array(3) {
[0]=>
string(10) "Litigation"
[1]=>
string(8) "Verdicts"
[2]=>
string(5) "Legal"
}
}
[5]=>
array(7) {
["title_en"]=>
string(40) "Vectura sues GSK for patent infringement"
["snippet_en"]=>
string(40) "Vectura sues GSK for patent infringement"
["url"]=>
string(91) "https://www.lifesciencesipreview.com/americas/vectura-sues-gsk-for-patent-infringement-1606"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/c855f2f1-13cc-49f1-9390-567782c9fdef"
["source"]=>
string(24) "lifesciencesipreview.com"
["publication_date"]=>
string(10) "2016-07-29"
["categories"]=>
array(3) {
[0]=>
string(21) "Intellectual Property"
[1]=>
string(5) "Legal"
[2]=>
string(10) "Litigation"
}
}
[6]=>
array(7) {
["title_en"]=>
string(74) "Paxil Class Action Settlement Approved for $40 Million - AboutLawsuits.com"
["snippet_en"]=>
string(154) "GlaxoSmithKline has agreed to pay $40 million to settle a Paxil class action lawsuit, which claims that the drug maker promoted the antidepressant for use"
["url"]=>
string(65) "https://www.aboutlawsuits.com/paxil-class-action-settlement-1247/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/96cfe893-8f59-4610-9257-d2d34361dd5c"
["source"]=>
string(17) "aboutlawsuits.com"
["publication_date"]=>
string(10) "2008-10-03"
["categories"]=>
array(5) {
[0]=>
string(15) "Corporate Fines"
[1]=>
string(14) "Product Launch"
[2]=>
string(10) "Litigation"
[3]=>
string(5) "Legal"
[4]=>
string(16) "Case Settlements"
}
}
[7]=>
array(7) {
["title_en"]=>
string(154) "IT WASN'T ONLY IN B&H THAT THERE WAS HUNTING IN THE MUD: The British company is suing Pfizer and BioNTech - "They stole our technology for covid vaccines""
["snippet_en"]=>
string(184) "Pfizer and BioNTech's Comirnaty vaccines infringe on GSK's patent-protected innovations in mRNA vaccines, developed 'more than a decade before' the covid-19 pandemic, the lawsuit says."
["url"]=>
string(170) "https://www.slobodna-bosna.ba/vijest/352902/nije_se_samo_u_bih_lovilo_u_mutnom_britanska_kompanija_tuzi_pfizer_i_biontech_ukrali_su_nasu_tehnologiju_za_covid_cjepiva.html"
["image_url"]=>
NULL
["source"]=>
string(17) "slobodna-bosna.ba"
["publication_date"]=>
NULL
["categories"]=>
array(4) {
[0]=>
string(8) "Epidemic"
[1]=>
string(21) "Intellectual Property"
[2]=>
string(5) "Legal"
[3]=>
string(10) "Litigation"
}
}
[8]=>
array(7) {
["title_en"]=>
string(70) "GlaxoSmithKline sues Pfizer, BioNTech over Covid-19 vaccine technology"
["snippet_en"]=>
string(196) "GSK said in the lawsuit that Pfizer and BioNTech's Comirnaty vaccines violate the company's patent rights in mRNA-vaccine innovations developed "more than a decade before" the outbreak of COVID-19"
["url"]=>
string(138) "https://www.business-standard.com/companies/news/glaxosmithkline-sues-pfizer-biontech-over-covid-19-vaccine-technology-124042501261_1.html"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/96e82326-958d-4aff-84c1-5e3bf085dda0"
["source"]=>
string(21) "business-standard.com"
["publication_date"]=>
NULL
["categories"]=>
array(5) {
[0]=>
string(8) "Epidemic"
[1]=>
string(21) "Intellectual Property"
[2]=>
string(24) "Access and affordability"
[3]=>
string(10) "Litigation"
[4]=>
string(5) "Legal"
}
}
}
["category_annotations"]=>
array(30) {
[0]=>
array(2) {
["name"]=>
string(13) "Collaboration"
["count"]=>
int(28)
}
[1]=>
array(2) {
["name"]=>
string(8) "Epidemic"
["count"]=>
int(26)
}
[2]=>
array(2) {
["name"]=>
string(12) "Stock Market"
["count"]=>
int(26)
}
[3]=>
array(2) {
["name"]=>
string(5) "Legal"
["count"]=>
int(21)
}
[4]=>
array(2) {
["name"]=>
string(11) "Acquisition"
["count"]=>
int(20)
}
[5]=>
array(2) {
["name"]=>
string(18) "General Investment"
["count"]=>
int(18)
}
[6]=>
array(2) {
["name"]=>
string(18) "Expansion & Growth"
["count"]=>
int(17)
}
[7]=>
array(2) {
["name"]=>
string(24) "Quarterly/Annual Figures"
["count"]=>
int(16)
}
[8]=>
array(2) {
["name"]=>
string(24) "Access and affordability"
["count"]=>
int(15)
}
[9]=>
array(2) {
["name"]=>
string(5) "Award"
["count"]=>
int(14)
}
[10]=>
array(2) {
["name"]=>
string(14) "Product Launch"
["count"]=>
int(14)
}
[11]=>
array(2) {
["name"]=>
string(31) "Financial Update/Profit Warning"
["count"]=>
int(13)
}
[12]=>
array(2) {
["name"]=>
string(5) "R & D"
["count"]=>
int(12)
}
[13]=>
array(2) {
["name"]=>
string(25) "Business Model Resilience"
["count"]=>
int(11)
}
[14]=>
array(2) {
["name"]=>
string(10) "Litigation"
["count"]=>
int(10)
}
[15]=>
array(2) {
["name"]=>
string(12) "Board Change"
["count"]=>
int(10)
}
[16]=>
array(2) {
["name"]=>
string(15) "Market Movement"
["count"]=>
int(9)
}
[17]=>
array(2) {
["name"]=>
string(20) "Business Development"
["count"]=>
int(9)
}
[18]=>
array(2) {
["name"]=>
string(13) "Data Security"
["count"]=>
int(8)
}
[19]=>
array(2) {
["name"]=>
string(16) "Customer Welfare"
["count"]=>
int(7)
}
[20]=>
array(2) {
["name"]=>
string(15) "Deals & Tenders"
["count"]=>
int(7)
}
[21]=>
array(2) {
["name"]=>
string(19) "Economic Conditions"
["count"]=>
int(6)
}
[22]=>
array(2) {
["name"]=>
string(46) "Management of Legal and Regulatory Environment"
["count"]=>
int(6)
}
[23]=>
array(2) {
["name"]=>
string(6) "Crisis"
["count"]=>
int(6)
}
[24]=>
array(2) {
["name"]=>
string(21) "Cultural developments"
["count"]=>
int(6)
}
[25]=>
array(2) {
["name"]=>
string(7) "Layoffs"
["count"]=>
int(6)
}
[26]=>
array(2) {
["name"]=>
string(10) "Divestment"
["count"]=>
int(6)
}
[27]=>
array(2) {
["name"]=>
string(24) "Employee Health & Safety"
["count"]=>
int(6)
}
[28]=>
array(2) {
["name"]=>
string(17) "Academic Research"
["count"]=>
int(5)
}
[29]=>
array(2) {
["name"]=>
string(24) "Stock Research & Ratings"
["count"]=>
int(5)
}
}
}
4abba-us-gsk-consumer-health-inc
Gsk Consumer Health, Inc.
Location
New Jersey
Founded
1994-02-28
Website
https://www.gsk.com
Articles
449 Articles
Category
Pharmaceutical Preparations
Description
GSK Consumer Healthcare is a global business that discovers, develops, and manufactures innovative consumer healthcare products. It is an associate of GlaxoSmithKline plc, one of the world's largest healthcare companies. GSK Consumer Healthcare aims to become one of the world's most innovative, best performing, and trusted healthcare companies. Their goal is to improve lives through scientific innovation, build category-defining brands, and become Pakistan's first and best Fast Moving Consumer Healthcare Company.
GlaxoSmithKline (GSK) has filed a lawsuit against Pfizer and BioNTech in Delaware federal court, alleging that the companies’ COVID-19 vaccines, Comirnaty,
GSK Consumer Health falsely advertises that its Emergen-C brand raspberry flavored immune supporting beverage mix contains “Natural fruit flavors,” a new class action lawsuit alleges.
GSK sued Pfizer this Wednesday before the General Court of Delaware (United States). The British pharmaceutical company alleges that the vaccine against Respiratory Syncytial Virus from the American giant (Abrysvo) violates the patent rights of its own (Arexvy), as published by the agency
A $6.5 million nationwide class settlement between GSK Consumer Health Inc. and customers alleging it deceptively marketed certain Benefiber products got the initial nod from a New York federal court.
Vectura Group said on Friday a British court had ruled in its favor on the packaging of a generic version of an inhaler made by bigger rival GlaxoSmithKline.
GlaxoSmithKline has agreed to pay $40 million to settle a Paxil class action lawsuit, which claims that the drug maker promoted the antidepressant for use
Pfizer and BioNTech's Comirnaty vaccines infringe on GSK's patent-protected innovations in mRNA vaccines, developed 'more than a decade before' the covid-19 pandemic, the lawsuit says.
GSK said in the lawsuit that Pfizer and BioNTech's Comirnaty vaccines violate the company's patent rights in mRNA-vaccine innovations developed "more than a decade before" the outbreak of COVID-19
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
